GIM
RCUS icon

Granahan Investment Management’s Arcus Biosciences RCUS Stock Holding History

Granahan Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-169,940
Closed -$4.05M – 162
2025
Q4 		$4.05M Sell
169,940
-285,656
-63% -$5.83M 0.17% 122
2025
Q3 		$6.2M Sell
455,596
-35,017
-7% -$364K 0.25% 82
2025
Q2 		$3.99M Buy
490,613
+11,023
+2% +$94.2K 0.16% 110
2025
Q1 		$3.76M Buy
479,590
+133,497
+39% +$1.55M 0.19% 112
2024
Q4 		$5.15M Sell
346,093
-11,745
-3% -$192K 0.22% 105
2024
Q3 		$5.47M Sell
357,838
-22,009
-6% -$347K 0.22% 120
2024
Q2 		$5.79M Buy
379,847
+83,277
+28% +$1.34M 0.23% 117
2024
Q1 		$5.6M Buy
296,570
+65,793
+29% +$1.14M 0.2% 127
2023
Q4 		$4.41M Buy
230,777
+35,178
+18% +$562K 0.15% 140
2023
Q3 		$3.51M Sell
195,599
-119,237
-38% -$2.4M 0.13% 142
2023
Q2 		$6.39M Sell
314,836
-261,912
-45% -$4.99M 0.2% 120
2023
Q1 		$10.5M Buy
576,748
+166,268
+41% +$3.18M 0.32% 86
2022
Q4 		$8.49M Buy
410,480
+67,145
+20% +$1.85M 0.26% 102
2022
Q3 		$8.98M Buy
343,335
+92,950
+37% +$2.46M 0.29% 92
2022
Q2 		$6.34M Buy
250,385
+24,335
+11% +$596K 0.22% 104
2022
Q1 		$7.13M Buy
226,050
+88,663
+65% +$2.97M 0.18% 116
2021
Q4 		$5.56M Buy
137,387
+32,539
+31% +$1.26M 0.11% 144
2021
Q3 		$3.66M Buy
+104,848
New +$3.26M 0.07% 167

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Granahan Investment Management's RCUS Position: Q1 2026 in Review

Granahan Investment Management sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 169,940 shares — an estimated $4.05M sold.

Granahan Investment Management first reported a position in RCUS in Q3 2021 and held it in 18 quarters. The position peaked at $10.5M in Q1 2023. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Granahan Investment Management reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
  • Granahan Investment Management sold 169,940 Arcus Biosciences shares in Q1 2026, an estimated $4.05M.
  • Granahan Investment Management first reported a position in Arcus Biosciences in Q3 2021 and held it in 18 quarters.
  • Granahan Investment Management's Arcus Biosciences position peaked at $10.5M in Q1 2023.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Granahan Investment Management's 13F filing for Q1 2026, filed 15 May 2026.